These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15578255)

  • 1. [Allogenic transplantation of human mesenchymal stem cells for tissue engineering purposes: an in vitro study].
    Niemeyer P; Seckinger A; Simank HG; Kasten P; Südkamp N; Krause U
    Orthopade; 2004 Dec; 33(12):1346-53. PubMed ID: 15578255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitro.
    Niemeyer P; Kornacker M; Mehlhorn A; Seckinger A; Vohrer J; Schmal H; Kasten P; Eckstein V; Südkamp NP; Krause U
    Tissue Eng; 2007 Jan; 13(1):111-21. PubMed ID: 17518585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mesenchymal stem cells for tissue engineering of bone: 3D-cultivation and osteogenic differentiation on mineralized collagen].
    Niemeyer P; Krause U; Punzel M; Fellenberg J; Simank HG
    Z Orthop Ihre Grenzgeb; 2003; 141(6):712-7. PubMed ID: 14679439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [EXPERIMENTAL RESEARCH OF IMMUNE SUPPRESSION ABILITY OF HUMAN BONE MARROW MESENCHYMAL STEM CELLS DURING DIFFERENTIATION].
    Su C; Su H; Wang P; Feng P; Wu Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2015 Aug; 29(8):1003-8. PubMed ID: 26677624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human neonatal thymus-derived mesenchymal stromal cells: characterization, differentiation, and immunomodulatory properties.
    Siepe M; Thomsen AR; Duerkopp N; Krause U; Förster K; Hezel P; Beyersdorf F; Schlensak C; Südkamp NP; Bosse R; Niemeyer P
    Tissue Eng Part A; 2009 Jul; 15(7):1787-96. PubMed ID: 19132892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and myogenic differentiation of mesenchymal stem cells for urologic tissue engineering.
    Wu R; Liu G; Bharadwaj S; Zhang Y
    Methods Mol Biol; 2013; 1001():65-80. PubMed ID: 23494421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic properties of differentiated and undifferentiated mesenchymal stem cells derived from umbilical cord blood.
    Lee HJ; Kang KS; Kang SY; Kim HS; Park SJ; Lee SY; Kim KD; Lee HC; Park JK; Paik WY; Lee L; Yeon SC
    J Vet Sci; 2016 Sep; 17(3):289-97. PubMed ID: 26726028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scaffold preferences of mesenchymal stromal cells and adipose-derived stem cells from green fluorescent protein transgenic mice influence the tissue engineering of bone.
    Wittenburg G; Flade V; Garbe AI; Lauer G; Labudde D
    Br J Oral Maxillofac Surg; 2014 May; 52(5):409-14. PubMed ID: 24685477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Osteoblasts derived from mesenchymal stem cells harbor immunoregulatory effect].
    Jiang XX; Zhang Y; Li XS; Wu Y; Yu XD; Tang PH; Mao N
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):50-3. PubMed ID: 15748435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Immune Response to Allogeneic Differentiated Mesenchymal Stem Cells in the Context of Bone Tissue Engineering.
    Kiernan CH; Wolvius EB; Brama PAJ; Farrell E
    Tissue Eng Part B Rev; 2018 Feb; 24(1):75-83. PubMed ID: 28816104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chondrogenic induction of mesenchymal stromal/stem cells from Wharton's jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering.
    Reppel L; Schiavi J; Charif N; Leger L; Yu H; Pinzano A; Henrionnet C; Stoltz JF; Bensoussan D; Huselstein C
    Stem Cell Res Ther; 2015 Dec; 6():260. PubMed ID: 26718750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.
    Tse WT; Pendleton JD; Beyer WM; Egalka MC; Guinan EC
    Transplantation; 2003 Feb; 75(3):389-97. PubMed ID: 12589164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human ethmoid sinus mucosa derived mesenchymal stem cells (hESMSCs) and the application of hESMSCs cell sheets in bone regeneration.
    Xie Q; Wang Z; Huang Y; Bi X; Zhou H; Lin M; Yu Z; Wang Y; Ni N; Sun J; Wu S; You Z; Guo C; Sun H; Wang Y; Gu P; Fan X
    Biomaterials; 2015 Oct; 66():67-82. PubMed ID: 26196534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune properties of human umbilical cord Wharton's jelly-derived cells.
    Weiss ML; Anderson C; Medicetty S; Seshareddy KB; Weiss RJ; VanderWerff I; Troyer D; McIntosh KR
    Stem Cells; 2008 Nov; 26(11):2865-74. PubMed ID: 18703664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR4 Activation Promotes Bone Marrow MSC Proliferation and Osteogenic Differentiation via Wnt3a and Wnt5a Signaling.
    He X; Wang H; Jin T; Xu Y; Mei L; Yang J
    PLoS One; 2016; 11(3):e0149876. PubMed ID: 26930594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune characterization of mesenchymal stem cells in human umbilical cord Wharton's jelly and derived cartilage cells.
    Liu S; Yuan M; Hou K; Zhang L; Zheng X; Zhao B; Sui X; Xu W; Lu S; Guo Q
    Cell Immunol; 2012; 278(1-2):35-44. PubMed ID: 23121974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regenerative therapy using allogeneic mesenchymal stem cells].
    Ohgushi H; Arima N; Taketani T
    Nihon Rinsho; 2011 Dec; 69(12):2121-7. PubMed ID: 22242308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of Osteoblastic Cells Derived from Bone Marrow and Adipose Tissue Associated with a Polymer/Ceramic Composite to Repair Bone Tissue.
    Freitas GP; Lopes HB; Almeida ALG; Abuna RPF; Gimenes R; Souza LEB; Covas DT; Beloti MM; Rosa AL
    Calcif Tissue Int; 2017 Sep; 101(3):312-320. PubMed ID: 28451713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vivo and in vitro bone regeneration from cord blood derived mesenchymal stem cells].
    Jäger M; Sager M; Knipper A; Degistirici O; Fischer J; Kögler G; Wernet P; Krauspe R
    Orthopade; 2004 Dec; 33(12):1361-72. PubMed ID: 15549251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells.
    Le Blanc K; Tammik C; Rosendahl K; Zetterberg E; Ringdén O
    Exp Hematol; 2003 Oct; 31(10):890-6. PubMed ID: 14550804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.